Robert C. Bayer

Robert C. Bayer

Robert C. Bayer

Bob has been involved in lobster research since the 1970s, and his primary interests are in the areas of lobster nutrition, management and pathology.  He obtained his B.S. in 1996 and his M.S. in 1968 from the University of Vermont, and his Ph.D. in 1972 from Michigan State University. 

In 2018, Bob retired as the Executive Director of the Lobster Institute. Bob is the Chief Science Officer at Lobster Unlimited, LLC, whose mission is to create innovative value-added products from lobster processing waste byproducts. Our long-term vision is to create commercial applications for such fishery processing byproducts, to add value throughout the value chain from lobsterman, to dealer, processor and biotech; building products that better the health of humanity and fuel Maine’s economy.

Bob has written or collaborated on dozens of articles for a variety of professional journals, and is the co-author of several books and industry manuals.  He is also the co-holder of two U.S. patents – one for the gaffkemia vaccine and the other for a method and solution for improving frozen seafood quality.  Bob is also known for his work with shell disease research, testing of artificial diets and baits for lobsters, developing tests for determining illegal removal of lobster eggs with chlorine bleach, and a variety of other research related to lobsters and the lobster industry. His most recent work includes making medicinals from lobster processing waste.